| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.102.1.118 |
| P698 | PubMed publication ID | 10880424 |
| P50 | author | Eugene Braunwald | Q322114 |
| P2093 | author name string | Hamm CW | |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | unstable angina | Q2032041 |
| P304 | page(s) | 118-122 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | A classification of unstable angina revisited | |
| P478 | volume | 102 |
| Q42113270 | A case of critical aortic stenosis masquerading as acute coronary syndrome |
| Q59356505 | ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the M |
| Q78304104 | Acute coronary lesions and troponin elevation in unstable angina pectoris or non-ST elevation acute myocardial infarction |
| Q34436586 | Acute coronary syndrome without ST elevation: implementation of new guidelines |
| Q34376944 | Acute coronary syndromes. The diagnostic role of troponins |
| Q53897107 | An ischemia-guided approach for risk stratification in patients with acute coronary syndromes. |
| Q28188525 | Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non-ST-elevation acute coronary syndromes |
| Q37608567 | Antithrombotic strategies in non-ST elevation acute coronary syndromes: focus on bivalirudin |
| Q44292399 | Applicability of a new definition of myocardial infarction and the opinion of Spanish cardiologists |
| Q84041835 | Association between OPG, RANK and RANKL gene polymorphisms and susceptibility to acute coronary syndrome in Korean population |
| Q97520530 | Association between Plasma Sestrin2 Levels and the Presence and Severity of Coronary Artery Disease |
| Q80352906 | Association between nitric oxide levels on myocardial injury in non-ST elevation acute coronary syndromes |
| Q84542675 | Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease |
| Q36333917 | Biomarkers in acute coronary syndromes and their role in diabetic patients |
| Q39418161 | Cardiac Troponins: Clinical and Analytical Aspects. |
| Q36302987 | Comparative effectiveness of diagnostic testing strategies in emergency department patients with chest pain: an analysis of downstream testing, interventions, and outcomes. |
| Q77616445 | Comparison of efficacy and complication rates after percutaneous coronary interventions in patients with and without renal insufficiency treated with abciximab |
| Q33718126 | Coronary Aneurysm Formation After Bioresorbable Vascular Scaffold Implantation Resulting in Acute Myocardial Infarction |
| Q33197102 | Delay of neutrophil apoptosis in acute coronary syndromes |
| Q93003094 | Diagnostic re-classification and prognostic risk stratification of patients with acute chest pain |
| Q36545963 | Differences between acute myocardial infarction and unstable angina: a longitudinal cohort study reporting findings from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions (RIKS-HIA). |
| Q53485774 | Differences in plaque composition and distribution in stable coronary artery disease versus acute coronary syndromes; non-invasive evaluation with multi-slice computed tomography. |
| Q37141941 | Drug-eluting stents: a review of current evidence on clinical effectiveness and late complications |
| Q85116160 | Early experience with a new approach for percutaneous intervention of totally occluded saphenous vein graft: is the flow the best thrombolytic? |
| Q35771807 | Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials |
| Q31168648 | Elevated troponin and ECG alterations in acute ischemic stroke and subarachnoid hemorrhage |
| Q27863325 | Enzymology of NAD+ homeostasis in man. |
| Q46575028 | Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes |
| Q24234760 | Factor Xa inhibitors for acute coronary syndromes |
| Q38889348 | High-sensitivity cardiac troponin assays and unstable angina |
| Q43695448 | Homozygosity for the C-->T polymorphism at nucleotide 46 in the 5' untranslated region of the factor XII gene protects from development of acute coronary syndrome |
| Q46959632 | Identification of biomarkers for unstable angina by plasma metabolomic profiling |
| Q31153582 | Immune-related chemotactic factors were found in acute coronary syndromes by bioinformatics |
| Q44244528 | Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study). |
| Q77111489 | Increased circulating monocyte activation in patients with unstable coronary syndromes |
| Q36348833 | Increasing serum troponin I and early prognosis in patients with chest pain or angina equivalent symptoms in the emergency department |
| Q77070045 | Interaction between heparin and cardiac troponin T and troponin I from patients after coronary bypass surgery |
| Q53660327 | Leakage of cardiac troponin I in aortic valve stenosis. |
| Q26747015 | Ligustrazine for the Treatment of Unstable Angina: A Meta-Analysis of 16 Randomized Controlled Trials |
| Q34635132 | Lipoprotein(a) Is the Best Single Marker in Assessing Unstable Angina Pectoris |
| Q34384281 | Lipoprotein-associated phospholipase A₂ is related to plaque stability and is a potential biomarker for acute coronary syndrome |
| Q35795319 | Markers to define ischemia: are they ready for prime time use in patients with acute coronary syndromes? |
| Q46947991 | Myocardial perfusion defects in patients with autoimmune diseases: a prospective study. Analysis of two diagnostic tests |
| Q51730474 | New methods to image unstable atherosclerotic plaques. |
| Q33355010 | Noninvasive diagnosis of ruptured peripheral atherosclerotic lesions and myocardial infarction by antibody profiling |
| Q39488600 | Not all ST-segment elevation myocardial infarctions become Q-wave myocardial infarctions |
| Q42056260 | Observed influence of nitroglycerine on myocardial perfusion scintigraphy in patients with multiple vessel coronary artery disease and well-developed collaterals |
| Q30474079 | Optical coherence tomography analysis of attenuated plaques detected by intravascular ultrasound in patients with acute coronary syndromes |
| Q73179579 | Outcomes of patients presenting with acute coronary syndromes and negative Troponin-T |
| Q33183129 | Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. |
| Q47808365 | Patients with unstable angina pectoris show an increased frequency of the Fc gamma RIIa R131 allele |
| Q77589997 | Plasma levels and vascular effects of endothelin and big endothelin in patients with stable and unstable angina pectoris undergoing coronary bypass grafting |
| Q34336824 | Platelet glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: initiate treatment early or wait for the catheterization laboratory? |
| Q36593847 | Predictors of Peak Troponin Level in Acute Coronary Syndromes: Prior Aspirin Use and SYNTAX Score |
| Q44136327 | Prevalence of coronary occlusion and outcome of an immediate invasive strategy in suspected acute myocardial infarction with and without ST-segment elevation |
| Q78353514 | Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classification |
| Q73438207 | Prognosis of patients with unstable angina and low-risk exercise test: significance of ST-segment depression on the admission ECG |
| Q28193778 | Prognostic factors in unstable angina with dynamic electrocardiographic changes. Value of fibrinogen |
| Q30396965 | Prognostic utility of cardiovascular magnetic resonance upright maximal treadmill exercise testing |
| Q77638355 | Prognostic value of continuous ST-segment monitoring in patients with non-ST-segment elevation acute coronary syndromes |
| Q37192668 | Prognostic value of low and moderately elevated C-reactive protein in acute coronary syndrome: a 2-year follow-up study |
| Q37533163 | Quality of Life in Patients with Coronary Artery Disease and Panic Disorder: A Comparative Study |
| Q46015310 | Rapid diagnosis of myocardial injury with troponin T and CK-MB relative index. |
| Q34189648 | Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease |
| Q40636563 | Release of cardiac troponin I after temporally graded acute coronary ischaemia with electrocardiographic ST depression |
| Q48591877 | Release pattern of N-terminal pro B-type natriuretic peptide (NT-proBNP) in acute coronary syndromes. |
| Q35691984 | Risk Stratification in Patients with Unstable Angina and Non-ST-elevation Myocardial Infarction |
| Q36236495 | Risk stratification of acute coronary syndrome patients. A multi-marker approach |
| Q34219090 | Risks and benefits of glycoprotein IIb/IIIa antagonists in acute coronary syndrome. |
| Q50569677 | Role of a streamer-like coronary thrombus in the genesis of unstable angina. |
| Q49716827 | Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial |
| Q36508782 | Serum cardiac markers in patients with acute myocardial infarction: oxidative stress, C-reactive protein and N-terminal probrain natriuretic Peptide |
| Q44992606 | Serum cardiac troponin I in acute stroke is related to serum cortisol and TNF-alpha |
| Q45800383 | Serum malondialdehyde levels, myeloperoxidase and catalase activities in patients with nephrotic syndrome. |
| Q43143068 | Serum myeloperoxidase levels and platelet activation parameters as diagnostic and prognostic markers in the course of coronary disease. |
| Q44612612 | Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). |
| Q59260465 | Studies towards hcTnI Immunodetection Using Electrochemical Approaches Based on Magnetic Microbeads |
| Q62011092 | Systemic inflammation in unstable angina is the result of myocardial necrosis |
| Q43803395 | Systolic blood pressure on admission predicts in-hospital mortality among patients presenting with acute coronary syndromes: the Greek study of acute coronary syndromes |
| Q34755446 | Test strategies for the detection of myocardial damage |
| Q35754326 | The reporting of cardiac troponin. |
| Q53547193 | The value of 64-slice computed tomography in a patient with an anomalous and atherosclerotic coronary artery. |
| Q36282559 | Troponin: think before you request one |
| Q40666251 | Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction |
| Q39282279 | Urinary neutrophil gelatinase-associated lipocalin as a predictor of cardiovascular events in patients with chronic kidney disease |
| Q24243766 | Xa inhibitors for acute coronary syndromes |
| Q81359097 | [Acute coronary syndrome: unstable angina and myocardial infarction] |
| Q78844764 | [Prognostic value of troponin T in hospitalized patients with angina or non-ST-segment elevation myocardial infarction] |
| Q78852049 | [Treatment of unstable angina: early invasive strategy] |
| Q26829973 | 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat |
Search more.